MUSCULAR DYSTROPHY, DUCHENNE
Clinical trials for MUSCULAR DYSTROPHY, DUCHENNE explained in plain language.
Never miss a new study
Get alerted when new MUSCULAR DYSTROPHY, DUCHENNE trials appear
Sign up with your email to follow new studies for MUSCULAR DYSTROPHY, DUCHENNE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy aims to slow muscle loss in duchenne MD
Disease control OngoingThis phase 3 trial tests whether a cell therapy called deramiocel (CAP-1002) can slow muscle decline in boys and young men with Duchenne muscular dystrophy (DMD). About 106 participants receive either the therapy or a placebo every 3 months for a year, then all can receive the th…
Matched conditions: MUSCULAR DYSTROPHY, DUCHENNE
Phase: PHASE3 • Sponsor: Capricor Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Higher doses of Gene-Targeting drug tested in boys with duchenne MD
Disease control OngoingThis study tests whether higher doses of the drug eteplirsen can safely help boys with Duchenne muscular dystrophy (DMD) who have a specific genetic mutation. About 160 boys who can still walk will receive different doses to see if it improves muscle strength and daily movement. …
Matched conditions: MUSCULAR DYSTROPHY, DUCHENNE
Phase: PHASE3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC